| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.4 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |